EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Letter to the Editor: Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration

Michael Colucciello iD

Journal of Ocular Pharmacology and Therapeutics · 2024

DOI: 10.1089/jop.2024.0013 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Michael Colucciello. Beteiligte Einrichtung: Clinical Associate, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Macular Degeneration, Wet Macular Degeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular DegenerationWet Macular DegenerationHumansEndothelial Growth FactorsRanibizumabAngiogenesis InhibitorsSteroidsIntravitreal InjectionsRetrospective Studies

Substanzen

Endothelial Growth FactorsRanibizumabAngiogenesis InhibitorsSteroids

Autor:innen und Institutionen

  • Clinical Associate, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
  • Retina Department, Prism Vision Group-South Jersey Eye Physicians Division, Moorestown, New Jersey, USA.

ORCID-Profile: Michael Colucciello

Zitieren

APA

Colucciello, M. (2024). Letter to the Editor: Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0013

Vancouver

Colucciello M. Letter to the Editor: Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2024.0013

BibTeX
@article{Colucciello2024,
  author = {Colucciello, Michael},
  title = {Letter to the Editor: Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.1089/jop.2024.0013}
}
Kostenlos starten →